S-3112

   Amend House File 555, as passed by the House, as follows:
   1.  Page 1, by striking lines 11 and 12.
   2.  Page 1, line 34, after <drug> by inserting <, biological product, or device>
   3.  Page 1, line 35, before <with> by inserting <or device>
   4.  Page 2, line 1, after <drug> by inserting <, biological product, or device>
   5.  Page 4, by striking lines 21 through 29.
   6.  Page 5, by striking lines 12 through 17.
   7.  Page 10, line 2, after <board.> by inserting <The board shall not develop or approve a statewide protocol permitting a pharmacist to order and administer any drug intended to induce an abortion as defined in section 146.l.>
   8.  Page 12, after line 10 by inserting: 
   <Sec. ___.  Section 514F.7, subsection 4, paragraph a, Code 2023, is amended to read as follows:
   a.  Prevent a health carrier, health benefit plan, or utilization review organization from requiring a covered person to try a prescription drug with the same generic name and demonstrated bioavailability or a biological product that is an interchangeable biological product pursuant to section 155A.32 

as defined in section 155A.3 prior to providing coverage for the equivalent branded prescription drug.>
   9.  Page 12, line 11, after <155A.6B,> by inserting <155A.11,>
   10.  By renumbering, redesignating, and correcting internal references as necessary.

______________________________
COMMITTEE ON HEALTH AND HUMAN SERVICES

JEFF EDLER, CHAIRPERSON